Global Neprilysin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Neprilysin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Neprilysin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neprilysin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Acute Heart Failure and Cancer Pain are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Neprilysin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Neprilysin key manufacturers include Bioprojet SCR, Novartis AG, Pharmaleads SA and Theravance Biopharma Inc, etc. Bioprojet SCR, Novartis AG, Pharmaleads SA are top 3 players and held % sales share in total in 2022.
Neprilysin can be divided into TD-0714, STR-324, PL-265 and LHW-090, etc. TD-0714 is the mainstream product in the market, accounting for % sales share globally in 2022.
Neprilysin is widely used in various fields, such as Acute Heart Failure, Cancer Pain, Hypertension and Alzheimer's Disease, etc. Acute Heart Failure provides greatest supports to the Neprilysin industry development. In 2022, global % sales of Neprilysin went into Acute Heart Failure filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Neprilysin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bioprojet SCR
Novartis AG
Pharmaleads SA
Theravance Biopharma Inc
Segment by Type
TD-0714
STR-324
PL-265
LHW-090
Others
Acute Heart Failure
Cancer Pain
Hypertension
Alzheimer's Disease
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Neprilysin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Neprilysin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Neprilysin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Neprilysin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Neprilysin introduction, etc. Neprilysin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Neprilysin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Neprilysin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Neprilysin key manufacturers include Bioprojet SCR, Novartis AG, Pharmaleads SA and Theravance Biopharma Inc, etc. Bioprojet SCR, Novartis AG, Pharmaleads SA are top 3 players and held % sales share in total in 2022.
Neprilysin can be divided into TD-0714, STR-324, PL-265 and LHW-090, etc. TD-0714 is the mainstream product in the market, accounting for % sales share globally in 2022.
Neprilysin is widely used in various fields, such as Acute Heart Failure, Cancer Pain, Hypertension and Alzheimer's Disease, etc. Acute Heart Failure provides greatest supports to the Neprilysin industry development. In 2022, global % sales of Neprilysin went into Acute Heart Failure filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Neprilysin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bioprojet SCR
Novartis AG
Pharmaleads SA
Theravance Biopharma Inc
Segment by Type
TD-0714
STR-324
PL-265
LHW-090
Others
Segment by Application
Acute Heart Failure
Cancer Pain
Hypertension
Alzheimer's Disease
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Neprilysin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Neprilysin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Neprilysin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Neprilysin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Neprilysin introduction, etc. Neprilysin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Neprilysin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.